Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

ZEN-BIO, INC.

UEI: LQS2WJFBBUQ3CAGE: 3MZW4

ZEN-BIO, INC. is a federal contractor, registered under UEI LQS2WJFBBUQ3 and CAGE code 3MZW4. It has been awarded $15,597,439 in federal contracts. Primary work spans Unknown NAICS, Biological Product (except Diagnostic) Manufacturing, and Medical Laboratories. Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Websitehttps://www.zen-bio.com

Address123 Main St, City, ST 12345

Registration

UEI Code

LQS2WJFBBUQ3

CAGE Code

3MZW4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325414Biological Product (except Diagnostic) Manufacturing(Primary)

541380Testing Laboratories and Services

541714Research and Development in Biotechnology (except Nanobiotechnology)

541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

621511Medical Laboratories

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ZEN-BIO, INC. specializes in the manufacturing and supply of high-purity biological products for advanced biomedical research and therapeutic development, with a primary focus on human-derived cellular and serological materials. The company delivers critical reagents including cord blood-derived CD3...

Key Performance Metrics

Awards Count

38

All time

Active

1

Currently performing

Completed

37

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$15.3M98.2%Department Of Defense$279.7K1.8%

Other agencies (1 agencies, <0.5% each)$4.6K0%

Awards by NAICS

- Unknown NAICS$14.5M93.2%

325414 - Biological Product (except Diagnostic) Manufacturing$468.3K3%621511 - Medical Laboratories$288.0K1.9%541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)$224.9K1.4%

Others - Other NAICS codes (2 codes, <0.5% each)$76.4K0.5%

Awards by Agency Over Time

Awards by Place of Performance

Compete with ZEN-BIO, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ZEN-BIO, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in ZEN-BIO, INC.'s top NAICS codes and agencies

Confirmatory Drug Testing Services (GC/MS)This subcontract involves providing high-complexity confirmatory drug testing services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize Gas Chromatography/Mass Spectrometry (GC/MS) to analyze samples that have triggered positive initial screens, ensuring that all certified confirmatory test reports are delivered within 72 hours of sample submission. To be eligible, the laboratory must be licensed and accredited within the State of Hawaii and fully equipped with the necessary GC/MS instrumentation. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

about 13 hours ago

DEADLINE

Initial Drug Screening Services (EMIT/Equivalent)This subcontract involves providing initial drug screening services for prime contractors working on projects for the Department of Judiciary in the State of Hawaii. The selected provider must utilize the EMIT system or an approved equivalent to execute Screening Panels I and II, which cover substances including amphetamines, cocaine, cannabinoids, opiates, alcohol, and fentanyl. All initial screening test results must be delivered within 72 hours of sample submission. To qualify, the provider must operate a laboratory equipped for rapid screening that maintains appropriate accreditation. This opportunity falls under NAICS code 621511 and has a response deadline of November 23, 2026.

Department of Judiciary

POSTED

about 13 hours ago

DEADLINE

Urine Specimen Collection ServicesThis subcontract for Urine Specimen Collection Services supports prime contractors on Department of Judiciary projects throughout the State of Hawaii. The selected subcontractor is responsible for the physical collection and secure delivery of urine specimens, operating seven days a week at designated facilities. To ensure the integrity of the process, the provider must adhere to strict, Judiciary-approved written procedures designed to prevent tampering. Eligible providers must maintain a physical collection facility located within the O‘ahu, Maui, Hawai‘i, or Kaua‘i circuits. This opportunity falls under NAICS code 621511, with a response deadline set for November 23, 2026.

Department of Judiciary

POSTED

about 13 hours ago

DEADLINE

Statewide Sample Collection, Drug Screen & Confirmatory Testing

Solicitation # J28030

The Department of Judiciary for the State of Hawaii is soliciting bids under solicitation J28030 for statewide sample collection, initial drug screening, and confirmation testing. The contractor is responsible for collecting urine specimens from individuals referred by the First, Second, Third, and Fifth Circuit courts at their own or an approved subcontractor's facilities. Initial screenings must utilize the EMIT system or an approved equivalent, while confirmation testing must be performed using gas chromatography/mass spectrometry by a company licensed and accredited in Hawaii. The contractor must provide these services seven days a week and submit written procedures to the Officer-in-Charge to ensure samples are not tampered with during collection. The contract is for an initial twenty-four month term from July 1, 2027, through June 30, 2029, with the possibility of two additional twelve-month extensions. Award will be granted to the lowest responsive and responsible bidder, with preferences considered for Hawaii-based products and other statutory categories. Payment is based on the actual number of samples collected per month at the unit bid cost, with invoices submitted separately for each circuit. The contractor must maintain compliance with various Hawaii state laws, including tax clearances, unemployment insurance, and prepaid health care requirements.

Department of Judiciary

POSTED

about 13 hours ago

DEADLINE

U.S. Army Long Range Precision Munition Launched Effects Medium Range-Lethal Prototype Integration and Qualification

Solicitation # 11e09f87-099d-4282-abc4-f6a4ce589397

Department Of Defense

POSTED

about 18 hours ago

DEADLINE

Clinical STI Screening and Treatment ServicesThe Clinical STI Screening and Treatment Services subcontract involves providing clinical screening, diagnosis, and medical management of sexually transmitted infections for prime contractors working on East Riding of Yorkshire Council sexual health projects. The scope of work specifically emphasizes Chlamydia screening for females aged 15 to 24 and the early detection of HIV to minimize late-stage presentations. These services are delivered using clinical diagnostic tools and medical examination facilities to ensure patients are accurately diagnosed and treated. The contract is aligned with the Public Health Outcomes Framework indicators, with a primary focus on delivering treated patients and reporting detection rates. Interested parties must respond by November 23, 2026, for this initiative managed by the East Riding of Yorkshire Council under NAICS code 621511.

East Riding of Yorkshire Council

POSTED

about 20 hours ago

DEADLINE

RRC Drug and Alcohol Testing Laboratory ServicesThis subcontract for Residential Reentry Center projects under the Department of Justice involves providing specialized drug and alcohol testing laboratory services for prime contractors. The selected provider will be responsible for the collection and analysis of urine samples to detect narcotics and alcohol, ensuring the delivery of accurate test results and comprehensive reporting. The service provider must maintain strict adherence to regulatory standards, specifically 42 CFR Part 493 (CLIA), P.S. 6060, and P.S. 6590. Performance for this contract is centered in Springfield, falling under NAICS code 621511. Responses are due by November 12, 2026.

Residential Reentry - Co

POSTED

about 23 hours ago

DEADLINE

Substance Abuse Testing and SurveillanceThis subcontract, titled Substance Abuse Testing and Surveillance, is issued by the Department of Justice for Residential Reentry projects. The selected provider will perform random drug and alcohol testing for prime contractors, utilizing urine surveillance, narcotic identification, and breathalyzer equipment. All activities, including testing intervals at facilities and during home visits, must be conducted in strict accordance with BOP P.S. 6060 and P.S. 6590 guidelines to ensure the delivery of verified results and compliance reports. The opportunity is categorized under NAICS code 621511 and was posted on October 28, 2026. Interested parties must submit their responses by the deadline of November 27, 2026.

Residential Reentry - Co

POSTED

about 23 hours ago

DEADLINE

AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING

Solicitation # FA7037-21-S-C001

The Air Force Cryptologic Office (AFCO) Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and innovative services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. The procurement process is divided into two phases: Phase I requires the submission of a quad chart and a white paper, while Phase II consists of full proposals by invitation only. Awards may be issued as traditional contracts or Other Transactions (OT), with potential funding ranging from 50,000 dollars to 50 million dollars over a period of performance lasting between one and five years. The evaluation process is based on technical merit, importance to agency programs, and fund availability, utilizing peer or scientific review to select offerors. Successful projects are expected to follow a structure of base period tasks to demonstrate feasibility, followed by option tasks for design, fabrication, testing, and evaluation. Because the work supports DoD ISR-Cyber capabilities, offerors must possess the necessary personnel and facility security clearances to handle classified work independently. All acquired technologies are treated as commercial items under 10 USC 3458 and DFARS 212.70. Submissions are managed by Carissa Heuertz, and the performance location is identified as San Antonio, Texas.

Department Of Defense

POSTED

about 23 hours ago

DEADLINE

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Solicitation # Project_1717

Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.

Supply Chain Coordination Limited

POSTED

about 24 hours ago

DEADLINE

in about 2 months

Pathology ServicesThis subcontract for Pathology Services involves providing diagnostic pathology support for prime contractors working on projects for the Kingston University Higher Education Corporation. The scope of work includes the collection of biological samples and the execution of laboratory analysis utilizing specialized diagnostic equipment and pathology software to deliver comprehensive test results and diagnostic reports. To ensure quality and compliance, the provider must hold recognized laboratory accreditation, such as ISO 15189 or equivalent UK standards. Interested parties must submit their responses by the deadline of November 27, 2026, as specified in the solicitation posted on October 28, 2026.

Kingston University Higher Education Corporation

POSTED

DEADLINE

REBID - IN HOUSE DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140325

The Port Authority of New York and New Jersey has issued solicitation number 6000003540 for a four year requirements contract to provide in house drug testing services. This procurement falls under NAICS code 621511 and NIGP codes 94874 for professional medical services and 19300 for clinical laboratory reagents and tests. The contract is designed to ensure the availability of drug monitoring and diagnostic testing services over a multi year period. Interested bidders must submit their proposals electronically via the Euna portal by the deadline of November 10, 2026. The Port Authority has ceased public bid openings, making electronic submission the only accepted method. In accordance with Title VI of the Civil Rights Act of 1964, the agency ensures full and fair opportunity for all businesses regardless of race, color, national origin, age, or disability. Procurement inquiries and submissions are managed by the Procurement Operations office located at 150 Greenwich Street, 21st Floor, New York, New York 10007.

The Port Authority of New York and New Jersey

POSTED

DEADLINE

REBID - FEDERAL DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140324

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003539, a four year requirements contract for federal drug testing services. This rebid covers professional medical services and clinical laboratory reagents and tests, specifically falling under NIGP codes 94874 and 19300. The contract will be performed state wide in New York. Bids must be submitted electronically via the Euna portal by November 10, 2026, at 11:00 AM, as the Port Authority has temporarily ceased public bid openings. All procurement activities are conducted in accordance with Title VI of the Civil Rights Act of 1964 to ensure full and fair opportunity without discrimination. For technical assistance or inquiries, the Procurement Operations Bid/RFP Custodian can be reached at [email hidden] or [phone hidden].

The Port Authority of New York and New Jersey

POSTED

DEADLINE

81627Y0875-Purchase of Raboravel V-RG Vaccines

Solicitation # 81627Y0875

The New York City Department of Health and Mental Hygiene (DOHMH) is seeking to establish a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the procurement of RABORAL V-RG coated sachet baits. This licensed oral rabies vaccine is used in the city's baiting program to immunize raccoons and reduce the transmission of rabies to other animals and humans. DOHMH has identified Boehringer Ingelheim as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Under the terms of the agreement, the vendor will provide up to 75,600 individual baits per contract year, sold in quantities of 300. Deliveries must be packed with cold packs and shipped to the NYC Public Health Laboratory at 455 First Avenue, New York, NY 10016, with each shipment accompanied by an invoice. Purchase quantities and delivery schedules will be determined by operational needs, including annual fall baiting campaigns, targeted spring baiting, or emergency responses to rabies outbreaks. Interested firms may submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

Department Of Health And Mental Hygiene

POSTED

DEADLINE

CAM ASSEMBLY, LOWER,

Solicitation # SPE7M4-27-T-1917

Solicitation SPE7M4-27-T-1917 is a request for quotations from the Defense Logistics Agency Weapons Support Fluid Handling Division for the procurement of 44 units of Lower Cam Assemblies, identified by NSN 1710-01-478-1569. The requirement is designated as a critical application item and is not a small business set-aside, though it incorporates a HUBZone price evaluation preference. Delivery is specified as FOB Origin with a required delivery date of February 10, 2029, and a delivery period of 590 days. The items are to be shipped to DLA Distribution San Diego. The contract mandates strict adherence to quality and security standards, including CMMC Level 2 self-assessment and the protection of covered defense information. Packaging must comply with ASTM D3951 and MIL-STD-129, with DLA Master List requirements taking precedence. Inspection and acceptance will occur at the destination, utilizing sampling methods per MIL-STD-1916 or ASQ H1331. Administrative requirements include electronic invoicing through the Wide Area WorkFlow system and compliance with the Buy American Act and Berry Amendment. Quotations must be submitted via DIBBS by November 9, 2026.

DLA WEAPONS SUPPORT FLUID HANDLING DIVISION

POSTED

DEADLINE

Clinical Blood Donor Panel Testing (Reference Laboratory Services)This subcontract involves providing clinical blood donor panel testing as a reference laboratory service for prime contractors supporting the Department of Veterans Affairs in North Chicago. The scope of work includes screening for various pathogens, including HIV, HBV, HCV, West Nile Virus, Chagas, Babesia, HTLV-I/II, and Anti-CMV, utilizing FDA-approved platforms. The service provider is responsible for managing specimen storage and conducting confirmation testing on all reactive results, with a strict requirement to deliver test result files within 24 hours. To ensure clinical quality and safety, the contractor must maintain CLIA certification and adhere to rigorous standards set by AABB, CAP, TJC, OSHA, the CDC, and the DoD. This opportunity falls under NAICS code 621511 and is managed through the Department of Veterans Affairs Network Contract Office 12.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Solicitation # 36C25227Q0071

The Department of Veterans Affairs is conducting market research via a sources sought synopsis to identify qualified providers for blood donor panel testing services at the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. This requirement, categorized under NAICS code 621511 for Medical Laboratories, involves a five year ordering period consisting of five one year priced periods starting March 1, 2027. The selected contractor must provide all labor, materials, and expertise to perform a variety of tests, including standard donor panels, Anti-CMV, Chagas Antibody, West Nile Virus, and Babesia DNA/RNA, with estimated annual quantities ranging from 15 to 6,200 tests per category. The contractor must adhere to strict regulatory standards from the FDA, AABB, CAP, TJC, OSHA, CDC, and Department of Defense. Key performance requirements include a 95 percent success rate for reporting results within 24 hours of specimen receipt, with confirmation testing completed within seven calendar days. The contractor is responsible for providing specimen shipment containers and maintaining all necessary certifications, including CLIA and FDA approvals. The government reserves the right to conduct physical inspections of the contractor's facilities. Interested parties must submit organizational details and tailored capability statements by November 3, 2026, to help the government determine if the contract will be a small business set-aside, sole sourced, or open for full competition.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.

Mrpbs Minneapolis Mn

POSTED

DEADLINE